Assessing a Novel Virtual Environment That Assists With Activities of Daily Living

Not Applicable

Completed

Conditions: Dementia
Alzheimer Disease
Neurodegenerative Diseases

Interventions: Device: A novel digital health device

Registration Number: NCT05418296

Lead Sponsor: mandy

Brief Summary: This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.

Detailed Description: Central themes in person-centered care are dignity/respect/choice for the care recipient.

This Phase l clinical study is a minimal risk study that focuses on how the new technology can support and amplify these principles, while assisting care staff.

The investigators will use a novel digital health device developed with user-centered design principles, mirroring a range of evidence-based non-pharmacological interventions for people living with Alzheimer's disease and its related dementias (AD/ADRD). This is a purpose-built virtual world depicting activities of daily living (ADLs). It contains interactive engagement stimuli, including customized digital artifacts that hold meaning to the person.

The investigators hypothesize that undertaking ADL-related virtual activities will support completions of actual ADLs, thereby increasing effectiveness and improving care outcomes.

Aim 1: Feasibility Successful outcomes are \>55% participation rate and a statistically significant difference between assessments of participation and non-participation, indicating tolerability and acceptability of routine interventions.

Aim 2: Effectiveness

Successful outcomes are:

* a reduction in ADL-related care challenges compared to baseline

* reduced time spent on the evening ADLs compared to baseline

* a reduction in negative response behaviors associated with the ADL

* greater interest in the ADL

* a positive shift in care staff attitudes

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 38

Inclusion Criteria

The subject will have a diagnosis of AD/ADRD, or symptoms of an undiagnosed AD/ADRD as observed by professional care staff and confirmed by the head of clinical care. The investigators will neither include nor exclude participation based on cognitive test scores. The subject will have had challenge(s) completing one or more ADLs in the previous month, as discussed at staff meetings, referenced in care plans, or observed/experienced by direct care staff.

Other specifications:

Understand English or Russian.
Can sit comfortably for at least 15 minutes in a chair/wheelchair at a table or propped up in bed or princess chair with a tray table
Are not known to be in pain
Have good vision, or good corrected vision (i.e., glasses)
Have good hearing, or good corrected hearing (i.e., aids)
May sometimes have anxiety or agitation when undertaking ADLs.

Exclusion Criteria

Ineligible subjects are those with significant non-AD/ADRD neurological, psychiatric, or physical impairment or those who are totally dependent upon others for ADLs.

Study & Design

Study Type: INTERVENTIONAL

Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Persons residing in long-term care homes	A novel digital health device	Subjects' ADLs are studied with intervention compared to baseline (without intervention).

Primary Outcome Measures

Name	Time	Method
Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL- Severe)	6 weeks	The ADCS-ADL assesses the competence of patients with Alzheimer's Disease (AD) in basic and instrumental activities of daily living (ADLs). It can be completed by a caregiver in questionnaire format, or administered by a clinician/researcher as a structured interview with a caregiver. There are 19 questions. The minimum and maximum values are 0 - 54. A higher score means a better outcome.
The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) The Minimum and Maximum Values Are A Higher Score Means a Better or Worse Outcome.	6 weeks	The NPI-NH The NPI-NH has been used to characterize the psychopathology of patients in nursing homes as well as to measure the impact of anti dementia and psychotropic drugs and behavioral changes in dementia patients dwelling in nursing homes. There are questions. The minimum and maximum values are 12 - 120 A lower score means a better outcome.

Secondary Outcome Measures

Name	Time	Method
The Copenhagen Burnout Index	6 weeks	The Copenhagen Burnout Inventory (CBI) is a 19-item survey that measures burnout in three areas: personal, work-related, and client-related. Scale ranges from 0 to 300, with high scores indicating high levels of burnout. This inventory is self-administered
Approaches to Dementia Questionnaire (ADQ)	6 weeks	The ADQ is a validated questionnaire that aims to assess participants' attitudes towards dementia, and has been shown to be reliable, easy to administer and to score. The ADQ is a 19-item survey that assesses attitudes towards people living with dementia using a five-point Likert scale ranging from 'strongly agree' to 'strongly disagree'. The total ADQ score ranges from 19 to 95, with higher scores reflecting more positive attitudes towards people living with dementia.
Sense of Competence in Dementia Care Staff (SCIDS) Scale	6 weeks	The SCIDS scale provides a useful and user-friendly means of measuring sense of competence in care staff. There are questions. The minimum and maximum values are 17 - 68 A higher score means a better outcome.

Trial Locations

Locations (2): Elder Ashram
🇺🇸
Oakland, California, United States
Bruceville Point Senior Living Community
🇺🇸
Elk Grove, California, United States